A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer's Disease Diagnosis Using Targeted Proteomics and Machine Learning.

Int J Mol Sci · 2023 · PMC10531486 · PMID 37762058

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

nominally significantp < 0.05actually significant

Pathway Analysis The proteins expressing a nominally significant difference ( p < 0.05) between the AD and the control groups were investigated using the expression analysis workflow in Ingenuity Pathway Analysis (Qiagen, Venlo, The Netherlands).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.